Replies to post #8097 on Calmare Therapeutics Inc (fka CTTC)

[powderbum]

I love all the negativity. Last time I checked The head of Palliative Care at the Mayo Clinic, Johns Hopkins and the University of Wisconsin were all still very excited about this technology. Why? Because it works and we are talking about a 600 billion dollar market.

Calmare will get its share of the market because it works and it has no side affects and it's non-addictive. Interest in the technology is picking up all over the country. The results of The U of Wisconsin double-blind study will out soon.

[Vaffan-Coulo]

Amazing indeed that they spent $78,000 on travel expenses for "trainers." Where are these trainers going that costs $78,000? That's like two years tuition at Harvard or Yale. How much is that per machine? And what are the trainers paid on top of that? Why does it even require in-person training? Why not just include a video or offer online training for an additional small fee?

Also amazing that they would neglect to offer some explanation of exactly how they incurred negative $7,000 in revenues. It seems like a company reporting negative revenues is a fairly rare event in the business world. I would think most company managements would feel compelled to offer shareholders something in the way of an explanation.

Someone mentioned optimism about the results of the double blind study. Chalmers was supposed to open something like a hundred clinics, right? Yet he ended up closing -- or maybe never even opened -- a Las Vegas office. He closed -- as inferred from its removal from the Spero website -- a Salt Lake City office. And he made the hometown office part of little more than a glorified beauty parlor. Evidently he's not too excited about the results of any upcoming trials.